Precision Neuroscience raises $250m at a $1bn valuation, NYT reports
Precision Neuroscience has raised $250m, co-led by Bill Ackman, at just over $1bn, The New York Times reports. The brain implant maker has now raised $430m in total.
Via TNW | Investors-funding
Precision Neuroscience has raised $250m in a Series D round for its brain-computer interface, the New York company announced on Thursday. Bill Ackman’s Pershing Square, the Ackman Oxman Institute and an unnamed life sciences fund led the round.
The round values Precision at just over $1bn, The New York Times reported. Pershing Square and the institute put in $42.5m of the total, according to the Times. Precision, which started in 2021, has now raised $430m in total.
Ackman’s first bet
Courtesy
This story was originally published by TNW | Investors-funding. All rights belong to the original publisher.
Read the original on thenextweb.com ↗